Review

Current analysis of urinary biomarkers for prostate cancer
  • Faruk Yencilek
  • Hakan Koyuncu
Bull Urooncol 2011; 10: 11-16
What are the New Developments in Urinary, Serum and Tissue Biomarkers in Prostate Cancer?
  • Hayrettin Şahin
  • Mehmet Çetinkaya
  • Hasan Deliktaş
Bull Urooncol 2017; 16: 95-100 DOI: 10.4274/uob.620
NON-PSA biomarkers for prostate cancer
  • Yarkın Kamil Yakupoğlu
  • Yakup Bostancı
  • Ender Özden
Bull Urooncol 2012; 11: 96-102
Evaluation of the Current Situation Tissue and Serum Biomarkers in Prostate Cancer
  • Enis Kervancıoğlu
  • Murat Koşan
Bull Urooncol 2015; 14: 102-107 DOI: 10.4274/uob.320
Diagnostic and Prognostic Molecular Features of Urothelial Bladder Cancer and New Treatment Approaches
  • Zafer Küçükodacı
  • Kutsal Yörükoğlu
Bull Urooncol 2015; 14: 258-270 DOI: 10.4274/uob.366

Review

Evaluation of Current Status of Urine and Serum Biomarkers in the Diagnosis and Follow-up of Bladder Cancer: Review
  • Mehmet Yıldızhan
  • Hakan Gemalmaz
Bull Urooncol 2019; 18: 127-134 DOI: 10.4274/uob.galenos.2015.588

Bph

Prostatic inflammation as a target of etiopathogenesis and treatment
  • Murat Koşan
  • Umut Gönülalan
Bull Urooncol 2013; 12: 247-250